Exact Mass: 471.1893074
Exact Mass Matches: 471.1893074
Found 500 metabolites which its exact mass value is equals to given mass value 471.1893074
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
PUROMYCIN
C22H29N7O5 (471.22300640000003)
An aminonucleoside antibiotic, derived from the Streptomyces alboniger bacterium, that causes premature chain termination during translation taking place in the ribosome. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D009676 - Noxae > D000963 - Antimetabolites C784 - Protein Synthesis Inhibitor D000970 - Antineoplastic Agents KEIO_ID P075; [MS2] KO009213 KEIO_ID P075
10-Formyldihydrofolate
10-Formyldihydrofolate is a folate compound that has not been found as a component of intracellular folates in normal tissues but has been identified in the cytosol of methotrexate (MTX)-treated MCF-7 breast cancer cells and normal human myeloid precursor cells. The origin of 10-formyldihydrofolate remains an enigma. Its appearance only in the extracts from MTX-treated cells is not consistent with a simple oxidation of lO-formyl-H4folate during the extraction procedure. This, however, does not exclude the occurrence of spontaneous oxidation of 10-formyl-H4folate within the intact cells prior to the folate extraction. (PMID: 3366769) [HMDB] 10-formyldihydrofolate is a folate compound that has not been found as a component of intracellular folates in normal tissues but has been identified in the cytosol of methotrexate (MTX)-treated MCF-7 breast cancer cells and normal human myeloid precursor cells. The origin of 10-formyldihydrofolate remains an enigma. Its appearance only in the extracts from MTX-treated cells is not consistent with a simple oxidation of lO-formyl-H4folate during the extraction procedure. This, however, does not exclude the occurrence of spontaneous oxidation of 10-formyl-H4folate within the intact cells prior to the folate extraction. (PMID: 3366769).
Dabigatran
C25H25N7O3 (471.20187799999997)
C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173066 - Direct Thrombin Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Hydroxydesmthyl doxepin glucuronide
Hydroxydesmthyl doxepin glucuronide is a metabolite of doxepin. Doxepin is a psychotropic agent with tricyclic antidepressant and anxiolytic properties, known under many brand-names such as Aponal, the original preparation by Boehringer-Mannheim, now part of the Roche group; Adapine, Doxal, Deptran, Sinquan and Sinequan. As doxepin hydrochloride, it is the active ingredient in cream-based preparations (Zonalon and Xepin) for the treatment of dermatological itch. (Wikipedia)
Norfluoxetine glucuronide
Norfluoxetine glucuronide is a metabolite of fluoxetine. Fluoxetine (also known by the tradenames Prozac, Sarafem, Fontex, among others) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. Fluoxetine was first documented in 1974 by scientists from Eli Lilly and Company. It was presented to the U.S. Food and Drug Administration in February 1977, with Eli Lilly receiving final approval to market the drug in December 1987. Fluoxetine went off-patent in August 2001 (Wikipedia).
N-(4-(2-(2,3-Dihydrobenzo(b)furan-7-carboxamido)ethyl)benzenesulfonyl)-N'-cyclohexylurea
C24H29N3O5S (471.18278240000006)
Dabigatran
C25H25N7O3 (471.20187799999997)
C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173066 - Direct Thrombin Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
5'-Guanidinonaltrindole
3-[3-Tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-propan-2-ylindol-2-yl]-2,2-dimethylpropanoic acid
C27H34ClNO2S (471.1998654000001)
D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors
puromycin
C22H29N7O5 (471.22300640000003)
5-formyl-tetrahydrofolate
5-formyl-tetrahydrofolate is a member of the class of compounds known as tetrahydrofolic acids. Tetrahydrofolic acids are heterocyclic compounds based on the 5,6,7,8-tetrahydropteroic acid skeleton conjugated with at least one L-glutamic acid unit. 5-formyl-tetrahydrofolate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 5-formyl-tetrahydrofolate can be found in a number of food items such as fennel, greenthread tea, orange mint, and coriander, which makes 5-formyl-tetrahydrofolate a potential biomarker for the consumption of these food products.
Zanubrutinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents D006401 - Hematologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
4-hydroxy-3-methoxyphenylacetonitrile 4-O-alpha-L-rhamnopyranosyl(1->6)-beta-D-glucopyranoside|adenophoraside C
C21H29NO11 (471.17405240000005)
(13R)-6alpha,7beta-dihydroxy-8beta,13-epoxy-11beta-nicotinyloxy-ent-clerodan-3-en-15,16-olide|scutelinquanine D
C26H33NO7 (471.22569080000005)
CAY10650
CAY10650 is a highly potent cytosolic phospholipase A2α (cPLA2α) inhibitor with an IC50 value of 12 nM. CAY10650 suppresses lipid droplets formation and PGE2 secretion[1][2].
Fluprostenol methyl amide
C24H32F3NO5 (471.22324580000003)
1H-Indole-2-propanoic acid, 1-[(4-chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-Alpha,Alpha-dimethyl-5-(1-methylethyl)- [CAS]
C27H34ClNO2S (471.1998654000001)
Ala His Met Asn
C18H29N7O6S (471.18999340000005)
Ala His Asn Met
C18H29N7O6S (471.18999340000005)
Ala Met His Asn
C18H29N7O6S (471.18999340000005)
Ala Met Asn His
C18H29N7O6S (471.18999340000005)
Ala Asn His Met
C18H29N7O6S (471.18999340000005)
Ala Asn Met His
C18H29N7O6S (471.18999340000005)
Cys Gly His Arg
C17H29N9O5S (471.20122640000005)
Cys Gly Arg His
C17H29N9O5S (471.20122640000005)
Cys His Gly Arg
C17H29N9O5S (471.20122640000005)
Cys His Asn Val
C18H29N7O6S (471.18999340000005)
Cys His Arg Gly
C17H29N9O5S (471.20122640000005)
Cys His Val Asn
C18H29N7O6S (471.18999340000005)
Cys Asn His Val
C18H29N7O6S (471.18999340000005)
Cys Asn Val His
C18H29N7O6S (471.18999340000005)
Cys Pro Pro Arg
C19H33N7O5S (471.2263768000001)
Cys Pro Arg Pro
C19H33N7O5S (471.2263768000001)
Cys Arg Gly His
C17H29N9O5S (471.20122640000005)
Cys Arg His Gly
C17H29N9O5S (471.20122640000005)
Cys Arg Pro Pro
C19H33N7O5S (471.2263768000001)
Cys Val His Asn
C18H29N7O6S (471.18999340000005)
Cys Val Asn His
C18H29N7O6S (471.18999340000005)
Asp His Asn Ser
C17H25N7O9 (471.17136800000003)
Asp His Ser Asn
C17H25N7O9 (471.17136800000003)
Asp Ile Pro Gln
C20H33N5O8 (471.23290180000004)
Asp Ile Gln Pro
C20H33N5O8 (471.23290180000004)
Asp Leu Pro Gln
C20H33N5O8 (471.23290180000004)
Asp Leu Gln Pro
C20H33N5O8 (471.23290180000004)
Asp Asn His Ser
C17H25N7O9 (471.17136800000003)
Asp Asn Ser His
C17H25N7O9 (471.17136800000003)
Asp Pro Ile Gln
C20H33N5O8 (471.23290180000004)
Asp Pro Leu Gln
C20H33N5O8 (471.23290180000004)
Asp Pro Gln Ile
C20H33N5O8 (471.23290180000004)
Asp Pro Gln Leu
C20H33N5O8 (471.23290180000004)
Asp Gln Ile Pro
C20H33N5O8 (471.23290180000004)
Asp Gln Leu Pro
C20H33N5O8 (471.23290180000004)
Asp Gln Pro Ile
C20H33N5O8 (471.23290180000004)
Asp Gln Pro Leu
C20H33N5O8 (471.23290180000004)
Asp Ser His Asn
C17H25N7O9 (471.17136800000003)
Asp Ser Asn His
C17H25N7O9 (471.17136800000003)
Glu Ile Asn Pro
C20H33N5O8 (471.23290180000004)
Glu Ile Pro Asn
C20H33N5O8 (471.23290180000004)
Glu Leu Asn Pro
C20H33N5O8 (471.23290180000004)
Glu Leu Pro Asn
C20H33N5O8 (471.23290180000004)
Glu Asn Ile Pro
C20H33N5O8 (471.23290180000004)
Glu Asn Leu Pro
C20H33N5O8 (471.23290180000004)
Glu Asn Pro Ile
C20H33N5O8 (471.23290180000004)
Glu Asn Pro Leu
C20H33N5O8 (471.23290180000004)
Glu Pro Ile Asn
C20H33N5O8 (471.23290180000004)
Glu Pro Leu Asn
C20H33N5O8 (471.23290180000004)
Glu Pro Asn Ile
C20H33N5O8 (471.23290180000004)
Glu Pro Asn Leu
C20H33N5O8 (471.23290180000004)
Glu Pro Gln Val
C20H33N5O8 (471.23290180000004)
Glu Pro Val Gln
C20H33N5O8 (471.23290180000004)
Glu Gln Pro Val
C20H33N5O8 (471.23290180000004)
Glu Gln Val Pro
C20H33N5O8 (471.23290180000004)
Glu Val Pro Gln
C20H33N5O8 (471.23290180000004)
Glu Val Gln Pro
C20H33N5O8 (471.23290180000004)
Gly Cys His Arg
C17H29N9O5S (471.20122640000005)
Gly Cys Arg His
C17H29N9O5S (471.20122640000005)
Gly His Cys Arg
C17H29N9O5S (471.20122640000005)
Gly His Lys Met
C19H33N7O5S (471.2263768000001)
Gly His Met Lys
C19H33N7O5S (471.2263768000001)
Gly His Met Gln
C18H29N7O6S (471.18999340000005)
Gly His Gln Met
C18H29N7O6S (471.18999340000005)
Gly His Arg Cys
C17H29N9O5S (471.20122640000005)
Gly Lys His Met
C19H33N7O5S (471.2263768000001)
Gly Lys Met His
C19H33N7O5S (471.2263768000001)
Gly Met His Lys
C19H33N7O5S (471.2263768000001)
Gly Met His Gln
C18H29N7O6S (471.18999340000005)
Gly Met Lys His
C19H33N7O5S (471.2263768000001)
Gly Met Gln His
C18H29N7O6S (471.18999340000005)
Gly Gln His Met
C18H29N7O6S (471.18999340000005)
Gly Gln Met His
C18H29N7O6S (471.18999340000005)
Gly Arg Cys His
C17H29N9O5S (471.20122640000005)
Gly Arg His Cys
C17H29N9O5S (471.20122640000005)
His Ala Met Asn
C18H29N7O6S (471.18999340000005)
His Ala Asn Met
C18H29N7O6S (471.18999340000005)
His Cys Gly Arg
C17H29N9O5S (471.20122640000005)
His Cys Asn Val
C18H29N7O6S (471.18999340000005)
His Cys Arg Gly
C17H29N9O5S (471.20122640000005)
His Cys Val Asn
C18H29N7O6S (471.18999340000005)
His Asp Asn Ser
C17H25N7O9 (471.17136800000003)
His Asp Ser Asn
C17H25N7O9 (471.17136800000003)
His Gly Cys Arg
C17H29N9O5S (471.20122640000005)
His Gly Lys Met
C19H33N7O5S (471.2263768000001)
His Gly Met Lys
C19H33N7O5S (471.2263768000001)
His Gly Met Gln
C18H29N7O6S (471.18999340000005)
His Gly Gln Met
C18H29N7O6S (471.18999340000005)
His Gly Arg Cys
C17H29N9O5S (471.20122640000005)
His Lys Gly Met
C19H33N7O5S (471.2263768000001)
His Lys Met Gly
C19H33N7O5S (471.2263768000001)
His Met Ala Asn
C18H29N7O6S (471.18999340000005)
His Met Gly Lys
C19H33N7O5S (471.2263768000001)
His Met Gly Gln
C18H29N7O6S (471.18999340000005)
His Met Lys Gly
C19H33N7O5S (471.2263768000001)
His Met Asn Ala
C18H29N7O6S (471.18999340000005)
His Met Gln Gly
C18H29N7O6S (471.18999340000005)
His Asn Ala Met
C18H29N7O6S (471.18999340000005)
His Asn Cys Val
C18H29N7O6S (471.18999340000005)
His Asn Asp Ser
C17H25N7O9 (471.17136800000003)
His Asn Met Ala
C18H29N7O6S (471.18999340000005)
His Asn Ser Asp
C17H25N7O9 (471.17136800000003)
His Asn Thr Thr
His Asn Val Cys
C18H29N7O6S (471.18999340000005)
His Gln Gly Met
C18H29N7O6S (471.18999340000005)
His Gln Met Gly
C18H29N7O6S (471.18999340000005)
His Gln Ser Thr
His Gln Thr Ser
His Arg Cys Gly
C17H29N9O5S (471.20122640000005)
His Arg Gly Cys
C17H29N9O5S (471.20122640000005)
His Ser Asp Asn
C17H25N7O9 (471.17136800000003)
His Ser Asn Asp
C17H25N7O9 (471.17136800000003)
His Ser Gln Thr
His Ser Thr Gln
His Thr Asn Thr
His Thr Gln Ser
His Thr Ser Gln
His Thr Thr Asn
His Val Cys Asn
C18H29N7O6S (471.18999340000005)
His Val Asn Cys
C18H29N7O6S (471.18999340000005)
Ile Asp Pro Gln
C20H33N5O8 (471.23290180000004)
Ile Asp Gln Pro
C20H33N5O8 (471.23290180000004)
Ile Glu Asn Pro
C20H33N5O8 (471.23290180000004)
Ile Glu Pro Asn
C20H33N5O8 (471.23290180000004)
Ile Asn Glu Pro
C20H33N5O8 (471.23290180000004)
Ile Asn Pro Glu
C20H33N5O8 (471.23290180000004)
Ile Pro Asp Gln
C20H33N5O8 (471.23290180000004)
Ile Pro Glu Asn
C20H33N5O8 (471.23290180000004)
Ile Pro Asn Glu
C20H33N5O8 (471.23290180000004)
Ile Pro Gln Asp
C20H33N5O8 (471.23290180000004)
Ile Gln Asp Pro
C20H33N5O8 (471.23290180000004)
Ile Gln Pro Asp
C20H33N5O8 (471.23290180000004)
Lys Gly His Met
C19H33N7O5S (471.2263768000001)
Lys Gly Met His
C19H33N7O5S (471.2263768000001)
Lys His Gly Met
C19H33N7O5S (471.2263768000001)
Lys His Met Gly
C19H33N7O5S (471.2263768000001)
Lys Met Gly His
C19H33N7O5S (471.2263768000001)
Lys Met His Gly
C19H33N7O5S (471.2263768000001)
Leu Asp Pro Gln
C20H33N5O8 (471.23290180000004)
Leu Asp Gln Pro
C20H33N5O8 (471.23290180000004)
Leu Glu Asn Pro
C20H33N5O8 (471.23290180000004)
Leu Glu Pro Asn
C20H33N5O8 (471.23290180000004)
Leu Asn Glu Pro
C20H33N5O8 (471.23290180000004)
Leu Asn Pro Glu
C20H33N5O8 (471.23290180000004)
Leu Pro Asp Gln
C20H33N5O8 (471.23290180000004)
Leu Pro Glu Asn
C20H33N5O8 (471.23290180000004)
Leu Pro Asn Glu
C20H33N5O8 (471.23290180000004)
Leu Pro Gln Asp
C20H33N5O8 (471.23290180000004)
Leu Gln Asp Pro
C20H33N5O8 (471.23290180000004)
Leu Gln Pro Asp
C20H33N5O8 (471.23290180000004)
Met Ala His Asn
C18H29N7O6S (471.18999340000005)
Met Ala Asn His
C18H29N7O6S (471.18999340000005)
Met Gly His Lys
C19H33N7O5S (471.2263768000001)
Met Gly His Gln
C18H29N7O6S (471.18999340000005)
Met Gly Lys His
C19H33N7O5S (471.2263768000001)
Met Gly Gln His
C18H29N7O6S (471.18999340000005)
Met His Ala Asn
C18H29N7O6S (471.18999340000005)
Met His Gly Lys
C19H33N7O5S (471.2263768000001)
Met His Gly Gln
C18H29N7O6S (471.18999340000005)
Met His Lys Gly
C19H33N7O5S (471.2263768000001)
Met His Asn Ala
C18H29N7O6S (471.18999340000005)
Met His Gln Gly
C18H29N7O6S (471.18999340000005)
Met Lys Gly His
C19H33N7O5S (471.2263768000001)
Met Lys His Gly
C19H33N7O5S (471.2263768000001)
Met Asn Ala His
C18H29N7O6S (471.18999340000005)
Met Asn His Ala
C18H29N7O6S (471.18999340000005)
Met Pro Pro Gln
C20H33N5O6S (471.2151438000001)
Met Pro Gln Pro
C20H33N5O6S (471.2151438000001)
Met Gln Gly His
C18H29N7O6S (471.18999340000005)
Met Gln His Gly
C18H29N7O6S (471.18999340000005)
Met Gln Pro Pro
C20H33N5O6S (471.2151438000001)
Asn Ala His Met
C18H29N7O6S (471.18999340000005)
Asn Ala Met His
C18H29N7O6S (471.18999340000005)
Asn Cys His Val
C18H29N7O6S (471.18999340000005)
Asn Cys Val His
C18H29N7O6S (471.18999340000005)
Asn Asp His Ser
C17H25N7O9 (471.17136800000003)
Asn Asp Ser His
C17H25N7O9 (471.17136800000003)
Asn Glu Ile Pro
C20H33N5O8 (471.23290180000004)
Asn Glu Leu Pro
C20H33N5O8 (471.23290180000004)
Asn Glu Pro Ile
C20H33N5O8 (471.23290180000004)
Asn Glu Pro Leu
C20H33N5O8 (471.23290180000004)
Asn His Ala Met
C18H29N7O6S (471.18999340000005)
Asn His Cys Val
C18H29N7O6S (471.18999340000005)
Asn His Asp Ser
C17H25N7O9 (471.17136800000003)
Asn His Met Ala
C18H29N7O6S (471.18999340000005)
Asn His Ser Asp
C17H25N7O9 (471.17136800000003)
Asn His Thr Thr
Asn His Val Cys
C18H29N7O6S (471.18999340000005)
Asn Ile Glu Pro
C20H33N5O8 (471.23290180000004)
Asn Ile Pro Glu
C20H33N5O8 (471.23290180000004)
Asn Leu Glu Pro
C20H33N5O8 (471.23290180000004)
Asn Leu Pro Glu
C20H33N5O8 (471.23290180000004)
Asn Met Ala His
C18H29N7O6S (471.18999340000005)
Asn Met His Ala
C18H29N7O6S (471.18999340000005)
Asn Asn Pro Gln
Asn Asn Gln Pro
Asn Pro Glu Ile
C20H33N5O8 (471.23290180000004)
Asn Pro Glu Leu
C20H33N5O8 (471.23290180000004)
Asn Pro Ile Glu
C20H33N5O8 (471.23290180000004)
Asn Pro Leu Glu
C20H33N5O8 (471.23290180000004)
Asn Pro Asn Gln
Asn Pro Gln Asn
Asn Gln Asn Pro
Asn Gln Pro Asn
Asn Ser Asp His
C17H25N7O9 (471.17136800000003)
Asn Ser His Asp
C17H25N7O9 (471.17136800000003)
Asn Thr His Thr
Asn Thr Thr His
Asn Val Cys His
C18H29N7O6S (471.18999340000005)
Asn Val His Cys
C18H29N7O6S (471.18999340000005)
Pro Cys Pro Arg
C19H33N7O5S (471.2263768000001)
Pro Cys Arg Pro
C19H33N7O5S (471.2263768000001)
Pro Asp Ile Gln
C20H33N5O8 (471.23290180000004)
Pro Asp Leu Gln
C20H33N5O8 (471.23290180000004)
Pro Asp Gln Ile
C20H33N5O8 (471.23290180000004)
Pro Asp Gln Leu
C20H33N5O8 (471.23290180000004)
Pro Glu Ile Asn
C20H33N5O8 (471.23290180000004)
Pro Glu Leu Asn
C20H33N5O8 (471.23290180000004)
Pro Glu Asn Ile
C20H33N5O8 (471.23290180000004)
Pro Glu Asn Leu
C20H33N5O8 (471.23290180000004)
Pro Glu Gln Val
C20H33N5O8 (471.23290180000004)
Pro Glu Val Gln
C20H33N5O8 (471.23290180000004)
Pro Ile Asp Gln
C20H33N5O8 (471.23290180000004)
Pro Ile Glu Asn
C20H33N5O8 (471.23290180000004)
Pro Ile Asn Glu
C20H33N5O8 (471.23290180000004)
Pro Ile Gln Asp
C20H33N5O8 (471.23290180000004)
Pro Leu Asp Gln
C20H33N5O8 (471.23290180000004)
Pro Leu Glu Asn
C20H33N5O8 (471.23290180000004)
Pro Leu Asn Glu
C20H33N5O8 (471.23290180000004)
Pro Leu Gln Asp
C20H33N5O8 (471.23290180000004)
Pro Met Pro Gln
C20H33N5O6S (471.2151438000001)
Pro Met Gln Pro
C20H33N5O6S (471.2151438000001)
Pro Asn Glu Ile
C20H33N5O8 (471.23290180000004)
Pro Asn Glu Leu
C20H33N5O8 (471.23290180000004)
Pro Asn Ile Glu
C20H33N5O8 (471.23290180000004)
Pro Asn Leu Glu
C20H33N5O8 (471.23290180000004)
Pro Asn Asn Gln
Pro Asn Gln Asn
Pro Pro Cys Arg
C19H33N7O5S (471.2263768000001)
Pro Pro Met Gln
C20H33N5O6S (471.2151438000001)
Pro Pro Gln Met
C20H33N5O6S (471.2151438000001)
Pro Pro Arg Cys
C19H33N7O5S (471.2263768000001)
Pro Gln Asp Ile
C20H33N5O8 (471.23290180000004)
Pro Gln Asp Leu
C20H33N5O8 (471.23290180000004)
Pro Gln Glu Val
C20H33N5O8 (471.23290180000004)
Pro Gln Ile Asp
C20H33N5O8 (471.23290180000004)
Pro Gln Leu Asp
C20H33N5O8 (471.23290180000004)
Pro Gln Met Pro
C20H33N5O6S (471.2151438000001)
Pro Gln Asn Asn
Pro Gln Pro Met
C20H33N5O6S (471.2151438000001)
Pro Gln Val Glu
C20H33N5O8 (471.23290180000004)
Pro Arg Cys Pro
C19H33N7O5S (471.2263768000001)
Pro Arg Pro Cys
C19H33N7O5S (471.2263768000001)
Pro Val Glu Gln
C20H33N5O8 (471.23290180000004)
Gln Gly His Met
C18H29N7O6S (471.18999340000005)
Gln Gly Met His
C18H29N7O6S (471.18999340000005)
Gln His Gly Met
C18H29N7O6S (471.18999340000005)
Gln His Met Gly
C18H29N7O6S (471.18999340000005)
Gln His Ser Thr
Gln His Thr Ser
Gln Met Gly His
C18H29N7O6S (471.18999340000005)
Gln Met His Gly
C18H29N7O6S (471.18999340000005)
Gln Met Pro Pro
C20H33N5O6S (471.2151438000001)
Gln Asn Asn Pro
Gln Asn Pro Asn
Gln Pro Met Pro
C20H33N5O6S (471.2151438000001)
Gln Pro Asn Asn
Gln Pro Pro Met
C20H33N5O6S (471.2151438000001)
Gln Ser His Thr
Gln Ser Thr His
Gln Thr His Ser
Gln Thr Ser His
Arg Cys Gly His
C17H29N9O5S (471.20122640000005)
Arg Cys His Gly
C17H29N9O5S (471.20122640000005)
Arg Cys Pro Pro
C19H33N7O5S (471.2263768000001)
Arg Gly Cys His
C17H29N9O5S (471.20122640000005)
Arg Gly His Cys
C17H29N9O5S (471.20122640000005)
Arg His Cys Gly
C17H29N9O5S (471.20122640000005)
Arg His Gly Cys
C17H29N9O5S (471.20122640000005)
Arg Pro Cys Pro
C19H33N7O5S (471.2263768000001)
Arg Pro Pro Cys
C19H33N7O5S (471.2263768000001)
Ser Asp His Asn
C17H25N7O9 (471.17136800000003)
Ser Asp Asn His
C17H25N7O9 (471.17136800000003)
Ser His Asp Asn
C17H25N7O9 (471.17136800000003)
Ser His Asn Asp
C17H25N7O9 (471.17136800000003)
Ser His Gln Thr
Ser His Thr Gln
Ser Asn Asp His
C17H25N7O9 (471.17136800000003)
Ser Asn His Asp
C17H25N7O9 (471.17136800000003)
Ser Gln His Thr
Ser Gln Thr His
Ser Thr His Gln
Ser Thr Gln His
Thr His Asn Thr
Thr His Gln Ser
Thr His Ser Gln
Thr His Thr Asn
Thr Asn His Thr
Thr Asn Thr His
Thr Gln His Ser
Thr Gln Ser His
Thr Ser His Gln
Thr Ser Gln His
Thr Thr His Asn
Thr Thr Asn His
Val Cys His Asn
C18H29N7O6S (471.18999340000005)
Val Cys Asn His
C18H29N7O6S (471.18999340000005)
Val His Cys Asn
C18H29N7O6S (471.18999340000005)
Val His Asn Cys
C18H29N7O6S (471.18999340000005)
Val Asn Cys His
C18H29N7O6S (471.18999340000005)
Val Asn His Cys
C18H29N7O6S (471.18999340000005)
MK 886
C27H34ClNO2S (471.1998654000001)
ETHYL 5-(2,4-BIS(BENZYLOXY)-5-ISOPROPYLPHENYL)ISOXAZOLE-3-CARBOXYLATE
C29H29NO5 (471.20456240000004)
Dimethyl 3,3-({3-acetamido-4-[(E)-(4-nitrophenyl)diazenyl]phenyl }imino)dipropanoate (non-preferred name)
Dorsomorphin 2HCl
Dorsomorphin (Compound C) dihydrochloride is a potent, selective and ATP-competitive AMPK inhibitor, with a Ki of 109 nM. Dorsomorphin dihydrochloride inhibits BMP pathway by targeting the type I receptors ALK2, ALK3, and ALK6. Dorsomorphin dihydrochloride can reverse autophagy activation and anti-inflammatory effect of Urolithin A (HY-100599).
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-7-methyl-N-(2-methylphenyl)- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-7-methyl-N-(3-methylphenyl)- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-7-methyl-N-(4-methylphenyl)- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,3-dimethylphenyl)-7-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,4-dimethylphenyl)-7-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,5-dimethylphenyl)-6-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,5-dimethylphenyl)-7-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2-ethylphenyl)-7-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(3,5-dimethylphenyl)-7-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(4-ethylphenyl)-6-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(4-ethylphenyl)-7-methyl- (9CI)
C28H29N3O2S (471.19803740000003)
Quinacrine dihydrochloride
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
2,2-[[3-acetamido-4-[(4-nitrophenyl)azo]phenyl]imino]diethyl diacetate
methyl N-[3-(acetylamino)-4-[(4-nitrophenyl)azo]phenyl]-N-(3-methoxy-3-oxopropyl)-beta-alaninate
Muramic acid,N-acetyl-1-O-(phenylmethyl)-4,6-O-(phenylmethylene)- (9CI)
2-[[7-(acetylamino)-6-(benzyloxy)-2-phenylperhydropyrano[3,2-d][1,3]dioxin-8-yl]oxy]propanoic acid
2-amino-N-[5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide
C22H29N7O5 (471.22300640000003)
LDS 751 dye
C25H30ClN3O4 (471.19247300000006)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes
Platensimycin A3 Methyl Ester
A polycyclic cage that is the methyl ester derivative of 7-hydroxy substituted platensimycin. It is isolated from Streptomyces platensis.
N-[1-[4-(2-methoxyphenyl)-1-piperazinyl]-1-thiophen-2-ylpropan-2-yl]benzenesulfonamide
C24H29N3O3S2 (471.16502440000005)
4-(2-Hydroxybenzylamino)-N-(3-(4-fluorophenoxy)phenyl)piperidine-1-sulfonamide
C24H26FN3O4S (471.1627968000001)
N-((1R,2S)-2-(5-chloro-1H-indole-2-carboxamido)cyclohexyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide
C23H26ClN5O2S (471.1495646000001)
N-((1R,2R)-2-(5-Chloro-1H-indole-2-carboxamido)cyclohexyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-C]pyridine-2-carboxamide
C23H26ClN5O2S (471.1495646000001)
2-[2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-YL)ethyl]-4-(4-ethoxy-1,1-biphenyl-4-YL)-4-oxobutanoic acid
Zanubrutinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents D006401 - Hematologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Citrovorum factor
D020011 - Protective Agents > D000931 - Antidotes D018977 - Micronutrients > D014815 - Vitamins
2-amino-N-[(2R,3R,4S,5S)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide
C22H29N7O5 (471.22300640000003)
2-[3a-[1-(furan-3-yl)-5,8a-dimethyl-3-oxo-4,6,7,8-tetrahydro-1H-isochromen-6-yl]-2,2-dimethyl-6-oxo-3,4,7,7a-tetrahydrofuro[3,2-c]pyran-3-yl]acetate
5-Formyltetrahydrofolate(2-)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
alpha-Neup5Ac-(2->6)-beta-D-Galp
alpha-Neup5Ac-(2->6)-D-Galp in which the anomeric configuration of the reducing-end D-galactose residue is beta.
Ansaetherone
C26H33NO7 (471.22569080000005)
An eleven-membered macrocyclic lactam that consists of (2S,3E,5Z,14S,15R)-5-ethylidene-11,14-dihydroxy-3,7,15-trimethyl-2,5-dihydro-2,13-ethano-1,9-benzoxazacycloundecine-6,8-dione in which the 14-hydroxy group is substituted by a (2R,5R,6R)-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl moiety. It is a radical scavenger isolated from Streptomyces.
Scutebarbatine G
C26H33NO7 (471.22569080000005)
A diterpene alkaloid of group of neo-clerodanes isolated from the whole plants of Scutellaria barbata and has been shown to exhibit neoplastic activity.
alpha-Neu5Ac-(2->3)-D-Gal
An amino disaccharide consisting of D-galactose having an alpha-N-acetylneuraminyl residue attached at the 3-position
1-[(4-fluorophenyl)methyl]-4-(3,4,5-trimethoxyphenyl)-4H-pyridine-3,5-dicarboxylic acid dimethyl ester
C25H26FNO7 (471.16932180000003)
2-nitro-N-[[4-[(1,2,3,4-tetrahydronaphthalen-2-ylmethylamino)methyl]cyclohexyl]methyl]benzenesulfonamide
C25H33N3O4S (471.2191658000001)
2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)-9-purinyl]-4-hydroxy-2-(hydroxymethyl)-3-oxolanyl]-3-(4-methoxyphenyl)propanamide
C22H29N7O5 (471.22300640000003)
alpha-Neup5Ac-(2->6)-D-Galp
An amino disaccharide consisting of D-galactose having an alpha-N-acetylneuraminyl residue attached at the 6-position
3-furanyl-[4-[3-(4-methoxyphenyl)-4-(trifluoromethyl)-2H-pyrazolo[3,4-b]pyridin-6-yl]-1-piperazinyl]methanone
C23H20F3N5O3 (471.1518166000001)
3-ethyl-2-[(E)-2-[(E)-(3-ethyl-5,6-dimethyl-1,3-benzothiazol-2-ylidene)methyl]but-1-enyl]benzo[g][1,3]benzothiazol-3-ium
3-[2,4-dioxo-1-[(4-oxo-2-pyrido[1,2-a]pyrimidinyl)methyl]-3-quinazolinyl]-N-(2-furanylmethyl)propanamide
C25H21N5O5 (471.15426160000004)
Platensimycin A4 Methyl Ester
A polycyclic cage compound isolated from Streptomyces platensis.
Platensimycin A1 Methyl Ester
A polycyclic cage that is the methyl ester derivative of platensimycin A1. It is isolated from Streptomyces platensis.
Platensimycin A2 Methyl Ester
A polycyclic cage that is the methyl ester derivative of 11-hydroxy substituted platensimycin. It is isolated from Streptomyces platensis.
5-Oxo-2-pyrrolidinecarboxylic acid [2-[3-(4-methoxyphenyl)-5-(2-naphthalenyl)-3,4-dihydropyrazol-2-yl]-2-oxoethyl] ester
(2S)-2-amino-N-[(2S,3S,4R)-5-[6-(dimethylamino)-9-purinyl]-4-hydroxy-2-(hydroxymethyl)-3-oxolanyl]-3-(4-methoxyphenyl)propanamide
C22H29N7O5 (471.22300640000003)
(4R,5R)-5-(2-azidophenyl)-2-[4-(3-hydroxypropoxy)phenyl]-4-(phenylmethyl)-5H-oxazole-4-carboxamide
3-O-{5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl}-alpha-D-galactopyranose
3-O-(5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranonosyl)-D-galactopyranose
2-[(2S,3S,6R)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C21H30FN3O6S (471.18392520000003)
N-[(5R,6S,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O7S (471.2039108000001)
N-[(5R,6R,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O7S (471.2039108000001)
2-[(2R,3R,6S)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(3-morpholin-4-ylpropyl)acetamide
C21H30FN3O6S (471.18392520000003)
(2R,3R,3aS,9bS)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-6-oxo-1-[oxo(2-pyrazinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-7-(3-methoxyphenyl)-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
C28H29N3O4 (471.21579540000005)
N-[(5R,6S,9R)-5-methoxy-8-(2-methoxyacetyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O7S (471.2039108000001)
N-[(5S,6R,9R)-5-methoxy-8-(2-methoxyacetyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O7S (471.2039108000001)
N-[(5S,6R,9S)-5-methoxy-8-(2-methoxyacetyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O7S (471.2039108000001)
2-[(2S,3R,6R)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(3-morpholin-4-ylpropyl)acetamide
C21H30FN3O6S (471.18392520000003)
2-[(2R,3S,6R)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C21H30FN3O6S (471.18392520000003)
(2R,3R,3aS,9bS)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-7-(3-methoxyphenyl)-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
C28H29N3O4 (471.21579540000005)
4-[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
C25H33N3O4S (471.2191658000001)
(2S)-2-[(4S,5R)-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
C25H33N3O4S (471.2191658000001)
N-[(5R,6R,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O7S (471.2039108000001)
N-[(5S,6S,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O7S (471.2039108000001)
2-[(2S,3R,6S)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C21H30FN3O6S (471.18392520000003)
2-[(2R,3R,6R)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C21H30FN3O6S (471.18392520000003)
N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
2-[(2R,5R,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2R,5R,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2S,5R,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1S,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(1R,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(1R,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
[(1S)-7-methoxy-1-[(3-methoxyphenyl)methyl]-2-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C24H29N3O5S (471.18278240000006)
(6R,7S,8S)-8-(hydroxymethyl)-N-(2-methoxyphenyl)-7-[4-(3-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C28H29N3O4 (471.21579540000005)
(6R,7R,8S)-8-(hydroxymethyl)-N-(2-methoxyphenyl)-7-[4-(3-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C28H29N3O4 (471.21579540000005)
4-[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
C25H33N3O4S (471.2191658000001)
4-[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
C25H33N3O4S (471.2191658000001)
3-[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
C25H33N3O4S (471.2191658000001)
3-[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
C25H33N3O4S (471.2191658000001)
N-[(5S,6S,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
C21H33N3O7S (471.2039108000001)
2-[(2R,3S,6S)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C21H30FN3O6S (471.18392520000003)
2-[(2S,3S,6S)-3-[(2-fluorophenyl)sulfonylamino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C21H30FN3O6S (471.18392520000003)
N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
2-[(2S,5R,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2R,5S,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2S,5S,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2R,5S,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1R,3R,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(1R,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(1S,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(1S,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(1S,3R,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
(2S,3S,3aR,9bR)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-6-oxo-1-[oxo(2-pyrazinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(6S,7S,8R)-8-(hydroxymethyl)-N-(2-methoxyphenyl)-7-[4-(3-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C28H29N3O4 (471.21579540000005)
(6S,7S,8S)-8-(hydroxymethyl)-N-(2-methoxyphenyl)-7-[4-(3-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C28H29N3O4 (471.21579540000005)
2-[[9-(1-Methylethyl)-6-[[3-(2-pyridinyl)phenyl]amino]-9H-purin-2-yl]amino]-1-butanol hydrochloride hydrate
5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-beta-D-galacto-hexopyranose
5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-alpha-D-galacto-hexopyranose
(2S)-2-amino-N-[(2S,4R,5R)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide
C22H29N7O5 (471.22300640000003)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1,3-dihydroxy-2-methyl-1-phenylpropan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C20H29N3O8S (471.16752740000004)
(2R,4S,5R,6R)-5-acetamido-2-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
(6S)-5-formyltetrahydrofolate(2-)
A dicarboxylic acid dianion arising from deprotonation of both carboxylic acid groups of (6S)-5-formyltetrahydrofolic acid.
MK886
C27H34ClNO2S (471.1998654000001)
D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors
5-Formyltetrahydrofolate(2-)
A dicarboxylic acid dianion obtained by deprotonation of the carboxy groups of 5-formyltetrahydrofolic acid.
10-Formyltetrahydrofolic acid
A form of tetrahydrofolate that acts as a donor of formyl groups in anabolism. In these reactions 10-formyltetrahydrofolic acid is used as a substrate in formyltransferase reactions, which is important in purine biosynthesis.
alpha-Neup5Ac-(2->3)-beta-D-Galp
An amino disaccharide consisting of beta-D-galactose having an alpha-N-acetylneuraminyl residue attached at the 3-position
alpha-Neup5Ac-(2->3)-alpha-D-GalpNAc
An amino disaccharide comprised of an N-acetyl-alpha-neuraminyl residue linked (2->3) to N-acetyl-alpha-D-galactosamine
10-formyltetrahydrofolate(2-)
Dianion of 10-formyltetrahydrofolic acid arising from deprotonation of both carboxylic acid functions.
Z-Gly-Arg-Thiobenzyl ester
C23H29N5O4S (471.19401540000007)
Z-Gly-Arg-Thiobenzyl ester is a chromogenic substrate for plasmogen-activated serine proteases[1].
n-[2,6-dihydroxy-3-(methoxycarbonyl)phenyl]-3-{10-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl}propanimidic acid
methyl 2-{8-[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-9-hydroxy-1-methyl-5,10-dioxo-3h-benzo[g]isochromen-3-yl}acetate
2-(4-{1-hydroxy-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-4-yl}phenoxy)-5-(hydroxymethyl)oxolane-3,4-diol
C26H33NO7 (471.22569080000005)
(2s)-2-amino-n-[(2s,4r,5r)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanimidic acid
C22H29N7O5 (471.22300640000003)
(1s,3s,12r,14r,27s)-3-[(2s)-butan-2-yl]-12,26-dihydroxy-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione
(6z,7z,9s,10r,11s)-6-ethylidene-3,14-dihydroxy-11-[(5-hydroxy-6-methyloxan-2-yl)oxy]-4,8,10-trimethyl-17-oxa-2-azatricyclo[7.6.2.0¹²,¹⁶]heptadeca-1(16),2,7,12,14-pentaen-5-one
C26H33NO7 (471.22569080000005)